Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 243.60 CHF | +0.92% |
|
+6.87% | - |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.14x | 4.56x | 1.28x | 6.12x | 18.32x | 25.63x | 0.95% | 49.06B | |
| 34.9x | 6.37x | -36.46x | 3.36x | 14.48x | 21.88x | -.--% | 44.6B | |
| -20.74x | 21.86x | -0.33x | 225.54x | -22.4x | -21.23x | -.--% | 43.24B | |
| 48.07x | 8.14x | 0.24x | 5.56x | 30.53x | 35.12x | -.--% | 41.73B | |
| 26.98x | 2.19x | 0.55x | 7.78x | 20.03x | 23.46x | 0.42% | 29.93B | |
| 35.03x | 25.13x | 2.32x | 5.75x | 26.11x | 27.32x | -.--% | 17.19B | |
| -61.09x | 30.62x | 49.65x | 9.99x | 243.97x | -1855.23x | -.--% | 15.35B | |
| 26.24x | 2.91x | 0.76x | 2.25x | 9.73x | 15.09x | 1.02% | 15.54B | |
| 78.28x | 4.67x | -0.34x | 4.13x | 15.8x | 19.68x | -.--% | 14.06B | |
| 29.8x | 1.41x | 0.29x | 1.95x | 11.98x | 13.65x | -.--% | 13.55B | |
| -447.65x | 2.93x | 4.71x | 13.73x | 81.56x | 106.71x | -.--% | 12.21B | |
| 52.48x | 4.58x | 2.75x | 8.71x | 24.72x | 29.48x | 0.44% | 11.37B | |
| 39.21x | 4.57x | 2.29x | 4.67x | 19.94x | 31.78x | 0.56% | 10.86B | |
| -28.92x | 8.41x | -5.86x | 76.27x | -19.13x | -18.59x | -.--% | 9.31B | |
| 30.63x | - | -0.09x | 16x | 29.21x | 28.53x | -.--% | 9.22B | |
| 23.47x | 2.48x | -20.47x | 4.67x | 12.53x | 15.98x | 0.3% | 9.31B | |
| -20.35x | 8.35x | 1.38x | 1700.15x | -21.76x | -22.16x | -.--% | 8.31B | |
| -20.56x | 7.1x | -6.73x | 8468.61x | -16.73x | -16.47x | -.--% | 7.98B | |
| Average | -7.78x | 8.60x | -0.23x | 586.96x | 26.61x | -85.52x | 0.21% | 20.16B | |
| Weighted average by Cap. | 6.01x | 9.21x | -2.52x | 258.88x | 23.61x | -60.43x | 0.25% |
Select your edition
All financial news and data tailored to specific country editions
